MicroRNA-506-3p initiates mesenchymal-to-epithelial transition and suppresses autophagy in osteosarcoma cells by directly targeting SPHK1

MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression

(2018) Wang Jiashi et al.   Aging-US

Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy

(2018) Fan Zhang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Upregulation of phosphorylated sphingosine kinase 1 expression in colitis-associated cancer

(2018) Kizuki Yuza et al.   JOURNAL OF SURGICAL RESEARCH

Identification of key gene modules for human osteosarcoma by co-expression analysis

(2018) Jing Zhang et al.   World Journal of Surgical Oncology

Autophagy inhibition impairs the epithelial-mesenchymal transition and enhances cisplatin sensitivity in nasopharyngeal carcinoma

(2017) Zhongwu Su et al.   Oncology Letters

microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview

(2017) Martino Marco Gabra et al.   Frontiers in Oncology

miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer

(2016) Zhi-Dong Lv et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling

(2016) J Li et al.   ONCOGENE

The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults

(2016) Iwona Lugowska et al.   TUMOR BIOLOGY

Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer

(2016) Mila Gugnoni et al.   Cell Death & Disease

The miR-506-Induced Epithelial–Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer

(2015) Shotaro Sakimura et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic factors and survival rate of osteosarcoma: A single-institution study

(2015) Wan Ismail Faisham et al.   Asia-Pacific Journal of Clinical Oncology

MIR517Cinhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation

(2015) Yuntao Lu et al.   Autophagy

Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition

(2015) Bing Tian et al.   BMC GENOMICS

Clinical implications of epithelial cell plasticity in cancer progression

(2015) Luis A. Aparicio et al.   CANCER LETTERS

Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer

(2013) Da Yang et al.   CANCER CELL

Epithelial-to-Mesenchymal Transition and Autophagy Induction in Breast Carcinoma Promote Escape from T-cell-Mediated Lysis

(2013) I. Akalay et al.   CANCER RESEARCH

Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial–mesenchymal transition

(2013) Jun Li et al.   CARCINOGENESIS

miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines

(2013) Himanshu Arora et al.   PLoS One

DEDD Interacts with PI3KC3 to Activate Autophagy and Attenuate Epithelial-Mesenchymal Transition in Human Breast Cancer

(2012) Q. Lv et al.   CANCER RESEARCH

EMT: A new vision of hypoxia promoting cancer progression

(2011) Jian Jiang et al.   CANCER BIOLOGY & THERAPY

Autophagy positively regulates the CD44+CD24-/lowbreast cancer stem-like phenotype

(2011) Sílvia Cufí et al.   CELL CYCLE

A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth

(2011) K L Streicher et al.   ONCOGENE

Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease

(2009) Hervé Acloque et al.   JOURNAL OF CLINICAL INVESTIGATION

EMT: When epithelial cells decide to become mesenchymal-like cells

(2009) Raghu Kalluri   JOURNAL OF CLINICAL INVESTIGATION

Targeting SphK1 as a New Strategy against Cancer

(2008) Dai Shida et al.   CURRENT DRUG TARGETS